US FDA grants full approval for Pfizer's cervical cancer drug-February 2024-www.financetom.com

US FDA grants full approval for Pfizer's cervical cancer drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA grants full approval for Pfizer's cervical cancer drug

Apr 29, 2024 1:21 PM

April 29 (Reuters) - The U.S. Food and Drug

Administration granted traditional approval for Pfizer's ( PFE )

drug for cervical cancer patients with disease progression on or

after chemotherapy, the agency said on Monday.

(Reporting by Pratik Jain in Bengaluru; Editing by Anil

D'Silva)

Previous page： Canacol Energy Posts 80% Increase in Q3 Net lncome Next page： Biogen Says EU Committee Recommends Approval of High Dose Nusinersen Regimen

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Canacol Energy Posts 80% Increase in Q3 Net lncome

Nov 17, 2025

07:52 AM EST, 11/17/2025 (MT Newswires) -- Colombia-focused Canacol Energy ( CNNEF ) reported Monday an 80% increase in net income for the third quarter. The natural gas exploration and production company booked a net income and comprehensive income of US$18.7 million, or $0.55 per share, in the three months ended Sept. 30, rising from $10.3 million, or $0.30 per...

Biogen Says EU Committee Recommends Approval of High Dose Nusinersen Regimen

Nov 17, 2025

07:51 AM EST, 11/17/2025 (MT Newswires) -- Biogen (BIIB) said Monday the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of a high dose regimen of nusinersen for the treatment of 5q spinal muscular atrophy. The CHMP's positive opinion will now be reviewed by the European Commission, with a final decision expected in January, the...

Novo Nordisk rolls out $349 Wegovy cash price ahead of plan

Nov 17, 2025

* Novo Nordisk cuts Wegovy price to $349 for cash payers early * Novo launches $199 deal for Wegovy, Ozempic lowest doses * GoodRx will launch a weight-loss telehealth service for $39 a month By Patrick Wingrove Nov 17 (Reuters) - Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to...

Palantir Technologies, FTAI Aviation Partner on Aircraft Maintenance Technology

Nov 17, 2025

07:50 AM EST, 11/17/2025 (MT Newswires) -- Palantir Technologies ( PLTR ) and FTAI Aviation ( FTAI ) said Monday it has formed a multi-year partnership. Financial terms were not disclosed. Under the deal, Palantir's ( PLTR ) AI will be incorporated into FTAI's aircraft maintenance operations worldwide . FTAI shares were up 3% in recent premarket activity. ...